GALIMI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 2.757
EU - Europa 1.242
AS - Asia 946
OC - Oceania 20
AF - Africa 8
SA - Sud America 5
Totale 4.978
Nazione #
US - Stati Uniti d'America 2.707
CN - Cina 549
IT - Italia 406
DE - Germania 158
SG - Singapore 121
IE - Irlanda 112
GB - Regno Unito 96
SE - Svezia 74
JP - Giappone 68
FI - Finlandia 63
FR - Francia 54
AT - Austria 50
CA - Canada 43
UA - Ucraina 43
IN - India 42
PL - Polonia 39
KR - Corea 35
HK - Hong Kong 29
NL - Olanda 27
VN - Vietnam 21
BE - Belgio 20
ES - Italia 19
AU - Australia 18
ID - Indonesia 18
TW - Taiwan 17
RU - Federazione Russa 16
CH - Svizzera 15
TR - Turchia 13
IR - Iran 9
CZ - Repubblica Ceca 8
DK - Danimarca 8
RO - Romania 8
TH - Thailandia 8
NO - Norvegia 6
MX - Messico 5
GR - Grecia 4
UZ - Uzbekistan 4
CO - Colombia 3
EE - Estonia 3
HU - Ungheria 3
LK - Sri Lanka 3
ZA - Sudafrica 3
DM - Dominica 2
EG - Egitto 2
IL - Israele 2
MK - Macedonia 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
AM - Armenia 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BR - Brasile 1
GH - Ghana 1
IM - Isola di Man 1
KZ - Kazakistan 1
PK - Pakistan 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UG - Uganda 1
Totale 4.978
Città #
Ann Arbor 509
Chandler 283
Fairfield 261
Beijing 145
Ashburn 135
Seattle 118
Woodbridge 116
Houston 102
Dublin 98
Singapore 88
Wilmington 88
Cambridge 87
Torino 83
Shanghai 72
Pisa 48
Vienna 48
Dearborn 41
Nyköping 36
Redwood City 35
Tokyo 30
Warsaw 30
New York 29
Jacksonville 28
Milan 27
Turin 27
Los Angeles 26
Princeton 26
Villeurbanne 24
Columbus 23
Guangzhou 23
Medford 22
Nanjing 21
Boardman 18
Brussels 18
Naples 18
San Diego 18
Jakarta 16
Taipei 16
Changsha 15
Manchester 15
Ottawa 15
Fremont 14
Helsinki 14
Lappeenranta 14
Santa Clara 14
Boston 13
Hangzhou 13
London 13
Genoa 12
Munich 12
Toronto 12
Chengdu 11
Dong Ket 11
Nanchang 11
Luni 10
Rome 10
Seoul 10
Shenyang 10
Wuhan 10
Amsterdam 9
Chongqing 9
Hong Kong 9
Paris 8
Salt Lake City 8
Austin 7
Chicago 7
Duncan 7
Fuzhou 7
Moscow 7
Pittsburgh 7
Zhengzhou 7
Buffalo 6
Central 6
Eitensheim 6
Heidelberg 6
Kocaeli 6
Nashville 6
Shenzhen 6
Silver Spring 6
Zurich 6
Bangkok 5
Barcelona 5
Bethesda 5
Birmingham 5
Bochum 5
Changchun 5
Gurgaon 5
Jinan 5
Madison 5
Melbourne 5
Berlin 4
Bologna 4
Brookline 4
Chatsworth 4
Delhi 4
Düsseldorf 4
Falls Church 4
Frankfurt am Main 4
Galway 4
Norwalk 4
Totale 3.328
Nome #
IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. 723
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 658
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer 335
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. 319
INHIBITION OF MEK AND PI3K/MTOR SUPPRESSES TUMOR GROWTH BUT DOES NOT CAUSE TUMOR REGRESSION IN PATIENT-DERIVED XENOGRAFTS OF RAS-MUTANT COLORECTAL CARCINOMAS 318
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer. 277
Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3. 258
Only a subset of Met-activated pathways are required to sustain oncogene addiction 250
HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment 246
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype 242
Genetic and expression analysis of MET, MACC1 and HGF in metastatic colorectal cancer: Response to Met inhibition in patient xenografts and pathological correlations 238
A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors. 220
Inhibition of Src impairs the growth of met-addicted gastric tumors. 213
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts 185
Anti-angiogenic and immunomodulatory effects of rapamycin on pancreatic islet endothelial cells: relevance for islets engraftment after transplantation 170
Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours 87
Met as a potential therapeutic target in basal-like breast cancer: An in vivo approach in a stem-cell perspective 82
Met as a potential therapeutic target in basal-like breast cancer 75
Identification and pre-clinical validation of surrogate soluble biomarkers correlating with therapeutic response to met inhibition 74
Signaling response to transient redox stress in human isolated T cells: Molecular sensor role of syk kinase and functional involvement of IL2 receptor and L-selectine 74
XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients 27
Totale 5.071
Categoria #
all - tutte 10.904
article - articoli 0
book - libri 0
conference - conferenze 1.412
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.316


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020471 0 0 0 0 55 87 80 57 67 49 42 34
2020/2021603 34 50 58 38 32 47 69 38 45 63 32 97
2021/20221.006 110 90 72 98 62 59 87 71 52 62 149 94
2022/2023736 73 77 31 78 52 149 41 64 70 16 44 41
2023/2024563 56 54 35 46 38 51 33 66 16 54 78 36
2024/2025319 26 35 98 71 89 0 0 0 0 0 0 0
Totale 5.071